Study of immune treatments at Mount Sinai
Part of Genetic & congenital, Immune system & allergy, Lungs & breathing clinical trials.
This study follows people who are receiving immune-related medications (called biologics or immune modulators) at Mount Sinai. It aims to better understand how these treatments affect the immune system and health over time, which may help improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 12 years old
- Be able to give consent (or have the right permission if needed)
- Get your medical care at Mount Sinai
- Currently be on a biologic or an immune-modulating medication at Mount Sinai
- Or, if the study team says so, be a comparison person who is not on the treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to understand the immune system in people who have immune problems or whose immune-related diseases are not helped by standard treatments. It may lead to better ways to diagnose and treat these conditions.
This study follows patients with inflammatory or autoimmune diseases that are not well controlled by standard treatments. Researchers want to learn how safe and effective new immune-modulating medications are when they are tried next.
This study collects blood and tissue samples from patients with rare immune system diseases that started in childhood, and from their relatives and healthy volunteers. The goal is to build a biocollection for future research to better understand these diseases.
This study screens people who may have an inherited immune system condition (like problems with immune cell growth or death) and their blood relatives. The goal is to understand the condition better by collecting blood samples for testing.
This trial tests a tool (a way of collecting health information) to help doctors make better diagnosis, prognosis, and treatment decisions for children with certain immune problems. It also includes healthy children (like relatives) as comparison groups, to see how well the tool works.
This study follows people with suspected or known inherited immune/allergy problems by collecting health information and blood. It may help researchers understand how immune systems and allergies behave over time and support future studies.
Hear when a new Autoimmune Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.